RUNX2 and cancer: Recently, extensive research has shown that Runx-2 is associated with metastasis of diverse types of cancers, such as breast and melanoma cancers, which are also potential targets for novel antimetastatic agents and diagnostic approaches for detecting cancer [21, 22].